0001958244-24-004547.txt : 20240916 0001958244-24-004547.hdr.sgml : 20240916 20240916173558 ACCESSION NUMBER: 0001958244-24-004547 CONFORMED SUBMISSION TYPE: 144 PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20240916 DATE AS OF CHANGE: 20240916 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: BioNTech SE CENTRAL INDEX KEY: 0001776985 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 SEC ACT: 1933 Act SEC FILE NUMBER: 001-39081 FILM NUMBER: 241302069 BUSINESS ADDRESS: STREET 1: AN DER GOLDGRUBE 12 CITY: MAINZ STATE: 2M ZIP: 55131 BUSINESS PHONE: 0049613190840 MAIL ADDRESS: STREET 1: AN DER GOLDGRUBE 12 CITY: MAINZ STATE: 2M ZIP: 55131 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: ATHOS KG CENTRAL INDEX KEY: 0001802897 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: 2M FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144 BUSINESS ADDRESS: STREET 1: BERGFELDSTRASSE 9 CITY: HOLZKIRCHEN STATE: 2M ZIP: 83607 BUSINESS PHONE: 0049802447059135 MAIL ADDRESS: STREET 1: BERGFELDSTRASSE 9 CITY: HOLZKIRCHEN STATE: 2M ZIP: 83607 144 1 primary_doc.xml 144 0001802897 XXXXXXXX LIVE 0001776985 BIONTECH SE 001-39081 An der Goldgrube 12 Mainz 2M 55131 49-6131-9084-0 ATHOS KG 10% Stockholder American Depositary Shares representing ordinary shares, no par value per share Goldman Sachs & Co. LLC 200 West Street New York NY 10282 500000 61700000 237725735 09/16/2024 NASD Ordinary Shares, no par value per share 01/05/2018 Private placement BioNTech SE N 500000 01/05/2018 Cash N AT Impf GmbH Rosenheimer Platz 6 Munich 2M 81669 American Depositary Shares representing ordinary shares, no par value per share 09/13/2024 170000 19552584 AT Impf GmbH Rosenheimer Platz 6 Munich 2M 81669 American Depositary Shares representing ordinary shares, no par value per share 09/16/2024 90000 11341611 The filing of this Form 144 shall not be construed as an admission that the undersigned is an affiliate of the issuer. All ADS to be sold by AT Impf GmbH. 09/16/2024 Goldman Sachs & Co. LLC on behalf of /s/ Thomas Maier /s/ Stephan Sperber